253 related articles for article (PubMed ID: 26821240)
1. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
Binder A; Rogers P; Hans G; Baron R
Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
[TBL] [Abstract][Full Text] [Related]
2. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
Ritchie M; Liedgens H; Nuijten M
Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
[TBL] [Abstract][Full Text] [Related]
6. 5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
Malec-Milewska M; Horosz B; Sękowska A; Kolęda I; Kucia H; Kosson D
Neurol Neurochir Pol; 2015; 49(1):24-8. PubMed ID: 25666769
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
10. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
Kontić M; Vičić-Hudorović V; Hudorović N
Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine plasters for postherpetic neuralgia?
BMJ Group
Drug Ther Bull; 2008 Feb; 46(2):14-6. PubMed ID: 18256177
[TBL] [Abstract][Full Text] [Related]
15. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
Garnock-Jones KP; Keating GM
Drugs; 2009 Oct; 69(15):2149-65. PubMed ID: 19791831
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact on quality of life of post-herpetic neuralgia in French medical centers specialized in chronic pain management: the ZOCAD study.
Laurent B; Vicaut E; Leplège A; Bloch K; Leutenegger E
Med Mal Infect; 2014 Dec; 44(11-12):515-24. PubMed ID: 25455078
[TBL] [Abstract][Full Text] [Related]
18. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
Kanai A; Okamoto T; Suzuki K; Niki Y; Okamoto H
Anesth Analg; 2010 May; 110(5):1457-60. PubMed ID: 20237042
[TBL] [Abstract][Full Text] [Related]
20. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
Rehm S; Binder A; Baron R
Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
